Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
Open Access
- 14 August 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in BMC Medicine
- Vol. 11 (1), 181
- https://doi.org/10.1186/1741-7015-11-181
Abstract
Exacerbations of chronic obstructive pulmonary disease (COPD) are important events that carry significant consequences for patients. Some patients experience frequent exacerbations, and are now recognized as a distinct clinical subgroup, the 'frequent exacerbator' phenotype. This is relatively stable over time, occurs across disease severity, and is associated with poorer health outcomes. These patients are therefore a priority for research and treatment. The pathophysiology underlying the frequent exacerbator phenotype is complex, with increased airway and systemic inflammation, dynamic lung hyperinflation, changes in lower airway bacterial colonization and a possible increased susceptibility to viral infection. Frequent exacerbators are also at increased risk from comorbid extrapulmonary diseases including cardiovascular disease, gastroesophageal reflux, depression, osteoporosis and cognitive impairment. Overall these patients have poorer health status, accelerated forced expiratory volume over 1 s (FEV1) decline, worsened quality of life, and increased hospital admissions and mortality, contributing to increased exacerbation susceptibility and perpetuation of the frequent exacerbator phenotype. This review article sets out the definition and importance of the frequent exacerbator phenotype, with a detailed examination of its pathophysiology, impact and interaction with other comorbidities.Keywords
This publication has 109 references indexed in Scilit:
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease PredictionThe New England Journal of Medicine, 2012
- Association of Chronic Obstructive Pulmonary Disease Maintenance Medication Adherence With All-Cause Hospitalization and Spending in a Medicare PopulationThe American Journal of Geriatric Pharmacotherapy, 2012
- Acute Exacerbations of Chronic Obstructive Pulmonary Disease and the Effect of Existing Psychiatric Comorbidity on Subsequent MortalityPsychosomatics, 2011
- Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® TrialLung, 2011
- Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costsRespiratory Medicine, 2011
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseThe New England Journal of Medicine, 2010
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary DiseaseArchives of Internal Medicine, 2010
- Determinants and impact of fatigue in patients with chronic obstructive pulmonary diseaseRespiratory Medicine, 2009
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJournal of the American College of Cardiology, 2006
- Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infectionsGenes & Immunity, 2003